[go: up one dir, main page]

Nguyen et al., 2007 - Google Patents

Understanding the role of von Willebrand factor and its cleaving protease ADAM TS13 in the pathophysiology of critical illness

Nguyen et al., 2007

Document ID
14725565490590607398
Author
Nguyen T
Carcillo J
Publication year
Publication venue
Pediatric Critical Care Medicine

External Links

Snippet

Most clinicians are well aware of von Willebrand's disease, the disorder associated with umbilical cord and surgical procedure bleeding. This disease is sometimes caused by a complete absence of von Willebrand factor (vWF) multimer but is most times caused by …
Continue reading at journals.lww.com (other versions)

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K35/00Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/12Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
    • A61K35/14Blood; Artificial blood

Similar Documents

Publication Publication Date Title
Uchino et al. Continuous venovenous hemofiltration without anticoagulation
Kornblith et al. The whole is greater than the sum of its parts: hemostatic profiles of whole blood variants
Chung et al. Incidence and predictors of post‐reperfusion syndrome in living donor liver transplantation
Ortmann et al. An exploratory cohort study comparing prothrombin complex concentrate and fresh frozen plasma for the treatment of coagulopathy after complex cardiac surgery
ten Cate Pathophysiology of disseminated intravascular coagulation in sepsis
Gajic et al. Fresh frozen plasma and platelet transfusion for nonbleeding patients in the intensive care unit: benefit or harm?
Gauvin et al. Association between length of storage of transfused red blood cells and multiple organ dysfunction syndrome in pediatric intensive care patients
Hellstern Solvent/detergent-treated plasma: composition, efficacy, and safety
Xia et al. Predictors of hyperkalemia in the prereperfusion, early postreperfusion, and late postreperfusion periods during adult liver transplantation
Bickmann et al. Novel targets for anticoagulants lacking bleeding risk
Darmon et al. Time course of organ dysfunction in thrombotic microangiopathy patients receiving either plasma perfusion or plasma exchange
Klages et al. Coagulation management in trauma-associated coagulopathy: allogenic blood products versus coagulation factor concentrates in trauma care
Joseph et al. An engineered activated factor V for the prevention and treatment of acute traumatic coagulopathy and bleeding in mice
Moe et al. Three-versus four-factor prothrombin complex concentrates for “factor-based” resuscitation in a porcine hemorrhagic shock model
Zhao et al. Cold‐stored platelets are effective in an in vitro model of massive transfusion protocol assessed by rotational thromboelastometry
Silliman et al. Mirasol Pathogen Reduction Technology® treatment does not affect acute lung injury in a two‐event in vivo model caused by stored blood components
Gallistl et al. Respective roles of factors II, VII, IX, and X in the procoagulant activity of FEIBA
Manco-Johnson et al. Activated protein C concentrate reverses purpura fulminans in severe genetic protein C deficiency
Nguyen et al. Understanding the role of von Willebrand factor and its cleaving protease ADAM TS13 in the pathophysiology of critical illness
Taketomi et al. Warfarin reversal with prothrombin complex concentrate confers better antifibrinolytic activity compared with recombinant activated factor VII
Sniecinski et al. Coagulopathy after cardiopulmonary bypass in Jehovah’s Witness patients: management of two cases using fractionated components and factor VIIa
Stief Thrombin generation by hemolysis
Davidson et al. Correlation between thrombin potential and bleeding after cardiac surgery in adults
Shiraboina et al. Predictors of postoperative cognitive dysfunction in adult patients undergoing elective cardiac surgery
Eltringham‐Smith et al. The fibrinogen but not the F actor VIII content of transfused plasma determines its effectiveness at reducing bleeding in coagulopathic mice